Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.01 +0.11 (+0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Eloxx Pharmaceuticals (ELOX) EPS (Diluted) (2021 - 2026)

Updated

Eloxx Pharmaceuticals (ELOX) recorded EPS (Diluted) of -$0.66 in Q2 2026, compared with -$5.45 a year earlier.

Analysis

Eloxx Pharmaceuticals (ELOX) EPS (Diluted) (2021 - 2026) Analysis & Trends

On a TTM basis, Eloxx Pharmaceuticals' EPS (Diluted) came in at -$1.75 as of Jun 30, 2026; for FY2025, it was -$5.34.

  • Across earlier years, EPS (Diluted) came in at -$9.20 in FY2024, -$72.98 in FY2023, -$183.13 in FY2022 and -$419.65 in FY2021.
  • The Q2 2026 figure is the highest quarterly EPS (Diluted) in data going back to Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.22
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.04
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.00
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.08
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.94
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.56
10 Eloxx Pharmaceuticals 87.58 Mn 13.90 Mn - -0.66
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.66
Mar 31, 2026 -0.86
Jun 30, 2025 -5.45
Mar 31, 2025 -4.94
Dec 31, 2023 -12.37
Sep 30, 2023 -14.38
Jun 30, 2023 -21.58
Mar 31, 2023 -31.63
Dec 31, 2022 -32.09
Sep 30, 2022 -38.12
Jun 30, 2022 -53.91
Mar 31, 2022 -59.00
Dec 31, 2021 -76.03
Sep 30, 2021 -50.45
Jun 30, 2021 -238.98
API Access

Eloxx Pharmaceuticals EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=ELOX&period=max&api_key=YOUR_API_KEY